Consolidated Statement Of Cash Flows

Fuji Pharma Co.,Ltd. - Filing #7726755

Concept As at
2018-03-31
2017-10-01 to
2018-03-31
As at
2017-09-30
As at
2017-03-31
2016-10-01 to
2017-03-31
As at
2016-09-30
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
2,644,000,000 JPY
2,132,000,000 JPY
Interest and dividends received
1,000,000 JPY
3,000,000 JPY
Interest paid
-32,000,000 JPY
-21,000,000 JPY
Income taxes paid
-911,000,000 JPY
-662,000,000 JPY
Net cash provided by (used in) operating activities
1,702,000,000 JPY
1,451,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-662,000,000 JPY
-720,000,000 JPY
Proceeds from sale of property, plant and equipment
1,272,000,000 JPY
0 JPY
Net cash provided by (used in) investing activities
-233,000,000 JPY
-780,000,000 JPY
Other, net
0 JPY
0 JPY
Cash flows from financing activities
Purchase of treasury shares
-40,000,000 JPY
JPY
Dividends paid
-374,000,000 JPY
-359,000,000 JPY
Repayments of long-term borrowings
-653,000,000 JPY
-1,460,000,000 JPY
Net cash provided by (used in) financing activities
-1,332,000,000 JPY
-2,003,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-15,000,000 JPY
15,000,000 JPY
Net increase (decrease) in cash and cash equivalents
121,000,000 JPY
-1,317,000,000 JPY
Cash and cash equivalents
5,624,000,000 JPY
5,503,000,000 JPY
5,497,000,000 JPY
6,815,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.